1. PTU-140 Vedolizumab is an effective therapy in postoperative ileal crohns following loss of response to anti-tnf. (17th June 2017) Authors: Saffouri, E; Kemp, L; Muir, A; Richardson, G; Morrison, P; Watts, D Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 051 Valproate and the risk for congenital malformations; is formulation and dosage regime important?. Issue 3 (9th February 2012) Authors: Mawhinney, E; Campbell, J; Craig, J; Russell, A; Smithson, W; Parsons, L; Robertson, I; Irwin, B; Morrison, P; Liggan, B; Delanty, N; Hunt, S; Morrow, J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83:Issue 3(2012) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A survey of the current clinical facilities for the management of familial cancer in Europe. Issue 8 (1st August 2000) Authors: Hodgson, S V; Haites, N E; Caligo, M; Chang-Claude, J; Eccles, D; Evans, G; Møller, P; Morrison, P; Steel, C M; Stoppa-Lyonnet, D; Vasen, H Journal: Journal of medical genetics Issue: Volume 37:Issue 8(2000) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗